Go to the main content

201
202
200
203
204

Address: Calwerstraße 14
72076 Tübingen


Person profile: 07071 29-82311


Fax number: 07071 29-4141


Current information on our studies

We regularly conduct scientific studies on various issues.

Study participants wanted!

We are looking for participants for many studies. Find out more about participating in a study.

Neuropsychiatric Study Center

Supports the GCP-compliant conduct of studies of the Center for Neurology, the University Department of Psychiatry and Psychotherapy and the Department of Neurosurgery by providing central services.

Learn more

Studies after diagnosis

Studies after diagnosis

Name of the study
Explanation
Contact
Links
Currently no ongoing studies



Name of the study
Explanation
Contact
Links
TBS-AH
Efficacy of bilateral theta burst stimulation in the treatment of auditory hallucinations in patients with schizophrenia.
zfh@med.uni-tuebingen.de
To the page
Information for Patients
ESPRIT-C2
Effects of transcranial direct current stimulation (tDCS) and cognitive training in patients with schizophrenia
zfh@med.uni-tuebingen.de

Biomarker evaluation to support clinical translation in schizophrenia

Start: 01.06.2021
Ende: 31.05.2024


Psychosis represents a group of diseases signified by enormous heterogeity. As a consequence, diagnosis, prognosis, and treatment decision for individual patients are pretty challenging. Within the project, we shall optimize biomarker signatures of patients with high risk for schizophrenia and with defined psychotic disease. This will be achieved by integration of multimodal patient data and subsequent validation of biomarker signatures with the help of patient-derived neurons.

Project leader: Prof. Dr. Hansjürgen Volkmer

Project funding: BMBF

Projektträger: DLR

Funding reference number: 01EK2101A




Name of the study
Explanation
Contact
Links
CBASP
Cognitive Behavioral Analysis System of Psychotherapy (CBASP) vs. Behavioral Activation (BA) in inpatients with persistent depressive and treatment-resistant disorders: Effectiveness, moderators, and mediators of change
christian.frischholz@med.uni-tuebingen.de


TBS-D
Effects of transcranial direct current stimulation (tDCS) and cognitive training in patients with schizophreniaEfficacy ofbilateral
theta burst stimulation in the treatment of depression.
zfh@med.uni-tuebingen.de

Go to page
Information for Patients
ERT
Treatment of depressive rumination using mindfulness meditation-based emotion regulation therapy. Meanwhile, examination of brain activity using fNIRS.
ert-studie@med.uni-tuebingen.de


Name of the study
Explanation
Contact
Links
Currently no ongoing studies



Name of the study
Explanation
Contact
Links
BI 1402-0012
Investigation of efficacy and safety of the drug BI 1358894 over 12 weeks in patients with borderline personality disorder
anne.rau@med.uni-tuebingen.de
Study flyer

Studies by method

Studies by method

Name of the study
Explanation
Contact
Links
CBASP
Cognitive Behavioral Analysis System of Psychotherapy (CBASP) vs. Behavioral Activation (BA) in inpatients with persistent depressive and treatment-resistant disorders: Effectiveness, moderators, and mediators of change
christian.frischholz@med.uni-tuebingen.de


TBS-AH
Efficacy of bilateral theta burst stimulation in the treatment of auditory hallucinations in patients with schizophrenia.
zfh@med.uni-tuebingen.de

To the page
Information for patients
TBS-D
Effects of transcranial direct current stimulation (tDCS) and cognitive training in patients with schizophreniaEfficacy of
bilateral theta burst stimulation in the treatment of depression.

zfh@med.uni-tuebingen.de
Go to page
Information for Patients
ESPRIT-C2
Effects of transcranial direct current stimulation (tDCS) and cognitive training in patients with schizophrenia
zfh@med.uni-tuebingen.de


ERT
Treatment of depressive rumination using mindfulness meditation-based emotion regulation therapy. Meanwhile, investigation of brain activity using fNIRS.
ert-studie@med.uni-tuebingen.de


BEDVAR

Study of eating behavior and reward processing. What processes promote the development of binge eating?

neuromadlab@klinikum.uni-tuebingen.de
Flyer
Name of the study
Explanation
Contact
Links
BipoLife NetBi-omics
One-time saliva donation for biodatabase - all (former) participants of the studies BipoLife A1, A2 and A3 can participate
anne.rau@med.uni-tuebingen.de

Biomarker evaluation to support clinical translation in schizophrenia

Start: 01.06.2021
Ende: 31.05.2024


Psychosis represents a group of diseases signified by enormous heterogeity. As a consequence, diagnosis, prognosis, and treatment decision for individual patients are pretty challenging. Within the project, we shall optimize biomarker signatures of patients with high risk for schizophrenia and with defined psychotic disease. This will be achieved by integration of multimodal patient data and subsequent validation of biomarker signatures with the help of patient-derived neurons.

Project leader: Prof. Dr. Hansjürgen Volkmer

Project funding: BMBF

Projektträger: DLR

Funding reference number: 01EK2101A



Certificates and Associations

Cookie Einstellungen
Bitte treffen Sie eine Auswahl um fortzufahren.
Weitere Informationen zu den Auswirkungen Ihrer Auswahl finden Sie unter Hilfe.
 
Um fortfahren zu können, müssen Sie eine Cookie-Auswahl treffen.

Cookies zulassen:
Wir setzen das Analysetool Google Analytics ein, um Besucher-Informationen wie z.B. Browser, Land, oder die Dauer, wie lange ein Benutzer auf unserer Seite verweilt, zu messen. Ihre IP-Adresse wird anonymisiert übertragen, die Verbindung zu Google ist verschlüsselt.

Nur notwendige Cookies zulassen:
Wir verzichten auf den Einsatz von Analysetools. Es werden jedoch technisch notwendige Cookies, die eine reibungslose Navigation und Nutzung der Webseite ermöglichen, gesetzt (beispielsweise den Zugang zum zugangsbeschränkten Bereich erlauben).

Sie können Ihre Cookie-Einstellung jederzeit auf der Seite Datenschutzerklärung ändern. Zum Impressum.

Zurück

Cookies zulassen Nur notwendige Cookies zulassen